Showing results (371-380 of 443) with videos related to

Sort By:
Pageof 45
Hepatology Communications|January 16, 2026
Preclinical development of mesothelin-targeting CAR T cells for the treatment of cholangiocarcinomaJinchutha Duangdara, Shaoli Lin, Jessica Hong, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
Temporal mapping of the anti-tumor effects of nanobody-based MSLN.CAR-T cell therapy in metastatic solid tumorsChaido Stathopoulou, Mingming Zhao, Qun Jiang, et al.
Nature Communications|March 12, 2015
Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesisWei Gao, Zhewei Tang, Yi-Fan Zhang, et al.
Antibody Therapeutics|February 26, 2019
Generation of antibody-based therapeutics targeting the Idiotype of B-cell MalignanciesEmily Weiss, Robert Sarnovsky, Mitchell Ho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Pretargeted alpha emitting radioimmunotherapy using (213)Bi 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid-biotinZhengsheng Yao, Meili Zhang, Kayhan Garmestani, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2009
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domainsCarmine Carpenito, Michael C Milone, Raffit Hassan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 16, 2023
Identification of nurse shark VNAR single-domain antibodies targeting the spike S2 subunit of SARS-CoV-2Jesse Buffington, Zhijian Duan, Hyung Joon Kwon, et al.
Antibody Therapeutics|November 9, 2018
Frontiers and Opportunities: Highlights of the 2nd Annual Conference of the Chinese Antibody SocietyHongyu Zhang, Mi Deng, Peng Lin, et al.
Journal of Cancer|May 26, 2011
HN125: A Novel Immunoadhesin Targeting MUC16 with Potential for Cancer TherapyXinran Xiang, Mingqian Feng, Mildred Felder, et al.
Molecular Therapy. Oncology|November 11, 2024
CAR-T cells based on a TCR mimic nanobody targeting HPV16 E6 exhibit antitumor activity against cervical cancerZhijian Duan, Dan Li, Nan Li, et al.
Pageof 45